Impact of Food and Drug Administration Regulations on the Performance of Guideline-Recommended Pathways With an Approved Point-of-Care High-Sensitivity Cardiac Troponin I Assay - Koechlin, L.; Boeddinghaus, J.; Lopez-Ayala, P.; Bianchi, C. L.; Nestelberger, T.; Wildi, K.; Miro, O.; Christ, M.; Rentsch, K.; Mahfoud, F.; Mueller, C.; dagger, Apace investigators (J Am Heart Assoc, 2025)
Keywords: journalArticle; Abbott, Polymedco, Dr Risch, and Siemens, all outside of the submitted work and; Akademische Gesellschaft Basel" and speaker honoraria from Roche Diagnostics,; Australia. Dr Mahfoud is supported by Deutsche Gesellschaft fur Kardiologie,; Basel; Bayer, Boehringer Ingelheim, Inari, Medtronic, Merck, ReCor Medical, Servier, and; Boehringer Ingelheim, BMS, Idorsia, Novartis, Osler, Roche, Sanofi, Singulex, and; Coulter, Bayer, Ortho Clinical Diagnostics and Orion Pharma, outside the; Deutsche Forschungsgemeinschaft (SFB TRR219, Project-ID 322900939), and Deutsche; Foundation, the Margarete und Walter Lichtenstein-Stiftung (3MS1038), and the; Foundation, the Swiss Heart Foundation, the University Hospital Basel, the; Foundation, the University of Basel, the Swiss Academy of Medical Sciences, and; Herzstiftung. Saarland University has received scientific support from Ablative; Hospital Foundation; Lopez-Ayala has received research grants from the Swiss Heart Foundation (FF20079; Medical Sciences, the Gottfried and Julia Bangerter-Rhyner Foundation, and; Novartis, LSI Medience Corporation, Ortho Clinical Diagnostics, Quidel, Roche,; Siemens, Singulex, Sphingotec, and SpinChip Diagnostics, as well as speaker; Solutions, Medtronic, and ReCor Medical. Until May 2024, Dr Mahfoud has received; SpinChip Diagnostics, all paid to the institution. The remaining authors have no; Terumo. Dr Mueller has received research support from the Swiss National Science; University Hospital Basel, as well as speaker/consulting honoraria or research; University of Basel and the Division of Internal Medicine, the Swiss Academy of; University of Basel, Abbott, Astra Zeneca, Beckman Coulter, Brahms, Idorsia,; and FF21103) and speaker's honoraria from Quidel, paid to the institution,; and a PhD scholarship from the University of Queensland, Brisbane,; biomarker; disclosures to report; honoraria/consulting honoraria from Abbott, Amgen, Astra Zeneca, Bayer,; myocardial infarction; outside the submitted work. Dr Nestelberger has received research support from; paid to the institution. Dr Boeddinghaus received research grants from the; speaker honoraria/consulting fees from Ablative Solutions, Amgen, AstraZeneca,; speaker honoraria/consulting honoraria from Siemens and Roche Diagnostics. Dr; submitted work. Dr Wildi received a research funding from the Prince Charles; support from Edwards Lifesciences, Boston Scientific, Medtronic, Abbott, Beckman; the Gottfried and Julia Bangerter-Rhyner Foundation, as well as the "Freiwillige; the Swiss National Science Foundation (P400PM_191037/1), the Prof. Dr Max Cloetta; the University of; the Wesley Medical Research Foundation; triage; troponin